We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
-0.73%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$32.6B
AUM Growth
+$1.87B
Cap. Flow
+$3.25B
Cap. Flow %
9.96%
Top 10 Hldgs %
9.03%
Holding
3,497
New
825
Increased
816
Reduced
580
Closed
693

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$213M
2
AVLR
Avalara, Inc.
AVLR
+$183M
3
BAX icon
Baxter International
BAX
+$173M
4
MMM icon
3M
MMM
+$172M
5
ADI icon
Analog Devices
ADI
+$164M

Top Sells

Rank Stock Value
1
BA icon
Boeing
BA
+$197M
2
TDG icon
TransDigm Group
TDG
+$181M
3
AAPL icon
Apple
AAPL
+$148M
4
ORCL icon
Oracle
ORCL
+$133M
5
ACC
American Campus Communities, Inc.
ACC
+$128M

Sector Composition

Rank Sector Weight
1 Industrials 11.59%
2 Technology 10.77%
3 Financials 10.58%
4 Consumer Discretionary 10.13%
5 Healthcare 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DTIL icon
2526
Precision BioSciences
DTIL
$201M
$25K ﹤0.01%
644
+265
+70% +$12.6K
KNSW.WS
2527
DELISTED
KnightSwan Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
KNSW.WS
$25K ﹤0.01%
175,000
– –
INFI
2528
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$25K ﹤0.01%
20,611
+3,488
+20% +$3.76K
PEARW
2529
DELISTED
Pear Therapeutics, Inc. Warrant
PEARW
$25K ﹤0.01%
150,000
– –
FTAAW
2530
DELISTED
FTAC Athena Acquisition Corp. Warrant
FTAAW
$25K ﹤0.01%
450,000
– –
GLS.WS
2531
DELISTED
Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
GLS.WS
$25K ﹤0.01%
500,000
– –
AFMD
2532
DELISTED
Affimed
AFMD
$24K ﹤0.01%
1,159
-513
-31% -$14.3K
RLX icon
2533
RLX Technology
RLX
$2.44B
$24K ﹤0.01%
+23,282
New +$35.6K
BURU.WS
2534
DELISTED
Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
BURU.WS
$24K ﹤0.01%
300,000
– –
DMS.WS
2535
DELISTED
Digital Media Solutions, Inc. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
DMS.WS
$24K ﹤0.01%
91,494
-158,506
-63% -$31.6K
WEJOW
2536
DELISTED
Wejo Group Limited Warrant
WEJOW
$24K ﹤0.01%
225,000
– –
AYLA
2537
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
$24K ﹤0.01%
+23,761
New +$32K
ABUS icon
2538
Arbutus Biopharma
ABUS
$906M
$23K ﹤0.01%
+12,249
New +$28.8K
QTTB icon
2539
Q32 Bio
QTTB
$458M
$23K ﹤0.01%
777
+115
+17% +$4.69K
GHIXW
2540
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
$23K ﹤0.01%
66,666
– –
SHPWW
2541
DELISTED
Shapeways Holdings, Inc. Warrants
SHPWW
$23K ﹤0.01%
500,000
– –
KORE.WS
2542
DELISTED
KORE Group Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
KORE.WS
$23K ﹤0.01%
194,873
– –
HMA.WS
2543
DELISTED
Heartland Media Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
HMA.WS
$23K ﹤0.01%
200,000
– –
ZTAQW
2544
DELISTED
Zimmer Energy Transition Acquisition Corp. Warrants
ZTAQW
$23K ﹤0.01%
66,666
– –
LVACW
2545
DELISTED
LAVA Medtech Acquisition Corp. Warrants
LVACW
$23K ﹤0.01%
187,500
– –
BRD.WS
2546
DELISTED
Beard Energy Transition Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
BRD.WS
$23K ﹤0.01%
150,000
– –
CCVI.WS
2547
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$22K ﹤0.01%
160,000
– –
TRAQ.WS
2548
DELISTED
Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
TRAQ.WS
$22K ﹤0.01%
200,000
– –
NPABW
2549
DELISTED
New Providence Acquisition Corp. II Warrant
NPABW
$22K ﹤0.01%
166,666
– –
CTMX icon
2550
CytomX Therapeutics
CTMX
$730M
$21K ﹤0.01%
14,794
-1,758
-11% -$2.71K
100 101
102
103 104

Similar funds

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Balyasny Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, Balyasny Asset Management held 3,497 positions worth $32.6B, up 6.1% from $30.7B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

Balyasny Asset Management deployed $3.25B of net new capital in Q3 2022, opening 825 new positions and adding to 816 existing holdings. Its largest new stake was Baxter International: 2,869,138 shares worth $155M.

By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Boeing, an estimated $197M trimmed.

  • Balyasny Asset Management's largest Q3 2022 buy was Baxter International: 2,869,138 shares worth $155M.
  • Balyasny Asset Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $213M increase.
  • Balyasny Asset Management's biggest Q3 2022 reduction was Boeing, cutting an estimated $197M.
  • Balyasny Asset Management fully exited TransDigm Group in Q3 2022, selling an estimated $181M.
  • Balyasny Asset Management's ten largest holdings make up 9% of its $32.6B portfolio in Q3 2022.
  • Balyasny Asset Management opened 825 new positions and closed 693 in Q3 2022.
  • Balyasny Asset Management's portfolio value rose 6.1% quarter-over-quarter to $32.6B.

Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.